Wagner, Soeren
Breitkopf, Martin
Ahrens, Elena
Ma, Haobo
Kuester, Olivia
Thomas, Christine
von Arnim, Christine A. F.
Walther, Andreas
Funding for this research was provided by:
Technische Universität München
Article History
Received: 18 September 2022
Accepted: 28 December 2022
First Online: 6 January 2023
Declarations
:
: This study was conducted in accordance with the guidelines for Good Clinical Practice and the Declaration of Helsinki due to ethical principles for medical research involving human subjects. The study approval was given by the local Ethics committee (Ethikkommission der Medizinischen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany) (reference number: 245_14 B, on 18.09.2014) (ClinicalTrials.gov ID: NCT02505815). Each patient read and signed a consent form before enclosed in the study. Informed consent was obtained from all participants.
: Not applicable.
: CAFvA received honoraria from serving on the scientific advisory board of Biogen, Roche, Novo Nordisk, MindAhead UG and Dr. Willmar Schwabe GmbH and has received funding for travel and speaker honoraria from Biogen, Roche diagnostics AG, Medical Tribune Verlagsgesellschaft mbH, Landesvereinigung für Gesundheit und Akademie für Sozialmedizin Niedersachsen e. V. and Dr. Willmar Schwabe GmbH and has received research support from Roche diagnostics AG and research funding from the Innovationsfond (Fund of the Federal Joint Committee, Gemeinsamer Bundesausschuss, G-BA Grants No. VF1_2016 − 201; 01NVF21010; 01VSF21019).The other authors declare that they have no conflicts of interest regarding the content of this article.